Fluconazole Treatment for Fungal UTI with >100,000 CFU
For fluconazole-susceptible organisms causing symptomatic fungal cystitis, treat with oral fluconazole 200 mg (3 mg/kg) daily for 2 weeks. 1
Dosing Algorithm
Standard Dosing (Normal Renal Function)
- Cystitis (lower UTI): Fluconazole 200 mg (3 mg/kg) daily for 2 weeks 1
- Pyelonephritis (upper UTI): Fluconazole 200-400 mg (3-6 mg/kg) daily for 2 weeks 1
The IDSA 2016 guidelines provide strong recommendations with moderate-quality evidence for cystitis dosing and low-quality evidence for pyelonephritis dosing. The higher dose range (400 mg) for pyelonephritis reflects the need for greater tissue penetration in upper tract infections.
Critical First Step: Remove Indwelling Catheters
Removal of bladder catheters is strongly recommended and should be done whenever feasible 1. This single intervention often leads to spontaneous resolution—one study showed 87-93% clearance at 8 weeks with catheter replacement alone 2. However, fluconazole accelerates clearance and provides more reliable eradication.
Renal Dose Adjustments
Fluconazole is 80% renally excreted as unchanged drug, making dose adjustment essential in renal impairment 3.
Dosing by Creatinine Clearance:
For multiple-dose therapy:
- Give full loading dose first (200-400 mg based on infection site) 3
- Then adjust maintenance dose:
- CrCl >50 mL/min: 100% of standard dose (no adjustment needed)
- CrCl ≤50 mL/min (no dialysis): 50% of standard dose
- Hemodialysis: 100% of recommended dose after each dialysis session; on non-dialysis days, give 50% dose 3
Practical Example:
- Patient with CrCl 35 mL/min and cystitis:
- Day 1: 200 mg loading dose
- Days 2-14: 100 mg daily (50% of standard 200 mg dose)
The half-life increases dramatically with renal impairment: from 36.7 hours with normal function to 101.9 hours when CrCl is 11-20 mL/min 4. This prolonged half-life justifies the dose reduction while maintaining therapeutic levels.
Species-Specific Considerations
Fluconazole-Susceptible Species (C. albicans, most C. parapsilosis):
- Use standard dosing as above 1
Fluconazole-Resistant C. glabrata:
- Cystitis: Amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days OR oral flucytosine 25 mg/kg 4 times daily for 7-10 days 1
- Pyelonephritis: Same agents, with option to combine AmB + flucytosine 1
C. krusei (inherently fluconazole-resistant):
- Amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days 1
When NOT to Treat
Asymptomatic candiduria does NOT require treatment in most patients 1. The guideline provides a strong recommendation against treatment unless the patient is:
- Neutropenic
- Very low-birth-weight infant (<1500 g)
- Undergoing urologic manipulation (treat prophylactically with fluconazole 400 mg daily for several days before and after procedure) 1
Common Pitfalls
- Treating asymptomatic candiduria: This is unnecessary in immunocompetent patients and leads to resistance without clinical benefit
- Forgetting renal dose adjustment: A 30% error rate in appropriate fluconazole dosing for renal impairment has been documented 5
- Not removing catheters: Leaving catheters in place significantly reduces treatment success
- Using echinocandins for UTI: These agents achieve inadequate urinary concentrations and should not be used for isolated UTI 6
- Inadequate treatment duration: The 2-week duration is necessary to prevent relapse 1
Monitoring
- Verify susceptibility testing before assuming fluconazole will work—C. glabrata has MIC90 of 64 mcg/mL compared to 12 mcg/mL for C. albicans 2
- Check transaminases if prolonged therapy needed—transient elevations occur in ~8% of patients 7
- Repeat urine culture 1-2 weeks after completion to confirm eradication
The evidence strongly supports fluconazole as first-line therapy for susceptible organisms, with the critical caveat that proper renal dosing and catheter management are essential for optimal outcomes.